Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v21-EN Version v1-EN
Language English English
Date Updated 2021-08-04 2020-02-12
Drug Identification Number 02431173 02431173
Brand name ESOMEPRAZOLE ESOMEPRAZOLE
Common or Proper name ESOMEPRAZOLE ESOMEPRAZOLE
Company Name SANIS HEALTH INC SANIS HEALTH INC
Ingredients ESOMEPRAZOLE ESOMEPRAZOLE
Strength(s) 40MG 40MG
Dosage form(s) TABLET (DELAYED-RELEASE) TABLET (DELAYED-RELEASE)
Route of administration ORAL ORAL
Packaging size 100 100
ATC code A02BC A02BC
ATC description DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD) DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD)
Reason for shortage Shortage of an inactive ingredient or component. Shortage of an inactive ingredient or component.
Anticipated start date 2020-03-26 2020-04-27
Actual start date 2020-03-24
Estimated end date 2021-07-30 2020-06-30
Actual end date 2021-08-03
Shortage status Resolved Anticipated shortage
Tier 3 Status No No
Company comments
Health Canada comments